StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

Diacerein

HCID 26248
Neue Reaktion
Drucken
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
112118-18-0
Standard-SMILES
CC(=O)Oc1cccc2c1C(=O)c1c(OC(C)=O)cc(C(=O)O)cc1C2=O
InChIKey
TYNLGDBUJLVSMA-UHFFFAOYSA-N
Summenformel
C19H12O8
Durchschnittliche Molmasse
368,3 g/mol
Monoisotopische Masse
368,05321734

Überblick

4,5-diacetyloxy-9,10-dioxo-2-anthracenecarboxylic acid is an anthraquinone.

Namen und Bezeichner

Bevorzugter Name
Diacerein
IUPAC
4,5-diacetyloxy-9,10-dioxoanthracene-2-carboxylic acid
Lokaler Name
Diacerein
Englischer Name
Diacerein
Summenformel
C19H12O8
Molmasse
368.29

Namen und Synonyme

Diacerein13739-02-1DiacetylrheinArtrodarDiacerheinFisiodar1,8-DIACETOXY-3-CARBOXYANTHRAQUINONEDiacereineSF-277DiacereinaVerborilZondar
Weitere Namen anzeigen
DARDiacerein impurity mixture CRSDiacetineSF 277ICN17261ICN 17261
Diora4,5-diacetyloxy-9,10-dioxoanthracene-2-carboxylic acidDiacereinumRhein diacetate2-Anthracenecarboxylic acid, 4,5-bis(acetyloxy)-9,10-dihydro-9,10-dioxo-M01AX214,5-Bis(acetyloxy)-9,10-dihydro-9,10-dioxo-2-anthracenecarboxylic AcidAC-201

Datenbank-Bezeichner

CAS
112118-18-0、13739-02-1
PubChem CID
26248
DTXSID
DTXSID4045636
ChEMBL
CHEMBL41286
ChEBI
CHEBI:94708
UNII
4HU6J11EL5
EC Number
237-310-2、839-256-0
Nikkaji
J14.479G

Eigenschaften

Berechnete Struktureigenschaften

XLogP
1,9
Polarare Oberfläche (TPSA)
124 Ų
H-Brücken-Donoren
1
H-Brücken-Akzeptoren
8
Frei drehbare Bindungen
5
Schwere Atome
27
Formalladung
0
Komplexität
683

Experimentelle und physikochemische Eigenschaften

DrugsPharmaceuticals -> Listed in ZINC15
Human DrugsPharmaceuticals
Collision Cross Section168.12 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physikochemische Eigenschaften

Schmelzpunkt
217 · 217-2180C
Siedepunkt
631.5 · 631.5±55.0 °C(Predicted)
Dichte
1.491 · 1.491±0.06 g/cm3(Predicted)
storage temp.
Sealed in dry,Room Temperature
Löslichkeit
DMSO (Sparingly), Methanol (Slightly)
Aggregatzustand
Solid
pka
3.01 · 3.01±0.20(Predicted)
Farbe
Light Yellow to Yellow
Wasserlöslichkeit
240 μg/L · 240μg/L at 25℃

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 6 Einträge

This chemical does not meet GHS hazard criteria for 3.3% (2 of 60) of reports.

Warning

H315 (96.7%): Causes skin irritation [Warning Skin corrosion/irritation]

P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 60 reports by companies from 7 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Not Classified

Gefahrenhinweise

Regulatory Information · 2 Einträge

REACH registered substance: Diacerein (EC: 237-310-2)

REACH registered substance: potassium;4,5-diacetoxy-9,10-dioxo-anthracene-2-carboxylate (EC: 839-256-0)

Hazard Classes and Categories · 2 Einträge

Skin Irrit. 2 (96.7%)

Not Classified

Toxikologische Informationen

Drug Induced Liver Injury · 4 Einträge

Drug-Induced Liver Injury Severity and Toxicity (DILIst)

Diacerein

DILI Positive

DOI:10.1016/j.drudis.2019.09.022

Sicherheitsdaten

wgk
3
hs_code
29146990
RTECS-Nr.
CB8781000

Chemie und Industrie

Pharmakologische Informationen

ATC Code · 2 Einträge

M - Musculo-skeletal system

QM - Musculo-skeletal system

Protein Binding99% of rhein is bound to plasma proteins.
PharmacodynamicsDecreases inflammation and cartilage destruction and also corrects altered osteoblast acitivity.
Mechanism of Action · 1 Eintrag

Diacerein's active metabolite rhein [DB13174] reduces cartilage destruction by decreasing expression of matrix metalloproteinase (MMP)-1 and -3 as well as upregulating tissue inhibitor of matrix metalloproteinases which serve to reduce the activity of several MMPs. The anti-inflammatory action of rhein reduces the level of interleukin-1beta activity which plays a large role in reduction of extracellular matrix production, MMP activity, and continued inflammation. Rhein reduces abnormal osteoblast synthetic activity through an unknown mechanism.

Biological Half-Life4-10h.
Metabolism/MetabolitesEntirely converted to rhien [DB13174] through double deacetylation before reaching systemic circulation. Rhein [DB13174] is further metabolized to rhein glucuronide and rhein sulfate.
MeSH Pharmacological ClassificationSubstances that reduce or suppress INFLAMMATION.
Absorption, Distribution and Excretion · 4 Einträge

Bioavailability of 50-60%. Entirely converted to the active metabolite rhein [DB13174] before reaching systemic circulation.

37% excreted in urine and 53% in feces as estimated in rats.

15-60L.

Total CL is 1.5L/h and renal CL is 0.1L/h.

Verwendung und Herstellung

Zugehörige Reaktionen

4
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 12937
HRID 12937als Edukt
Reaktionsgleichung von HRID 374653
HRID 374653als Edukt
Reaktionsgleichung von HRID 1908866
HRID 1908866als Edukt
Reaktionsgleichung von HRID 2379453
HRID 2379453als Edukt

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
Merck
14 · 14,2960
InChI
InChI=1S/C19H12O8/c1-8(20)26-13-5-3-4-11-15(13)18(23)16-12(17(11)22)6-10(19(24)25)7-14(16)27-9(2)21/h3-7H,1-2H3,(H,24,25)
InChIKey
TYNLGDBUJLVSMA-UHFFFAOYSA-N
SMILES
C1=C2C(C(=O)C3=C(C2=O)C=CC=C3OC(C)=O)=C(OC(C)=O)C=C1C(O)=O
LogP
3.126 · 3.126 (est)
CAS Datenbank
13739 · 13739-02-1(CAS DataBase Reference)
risk_code
36/37/38
Toxizität
rat,LD50,unreported,7500mg/kg (7500mg/kg),Drugs of the Future. Vol. 4, Pg. 445, 1979.
hazard_code
Xi
safety_code
26-36
Speicherklasse
11 - Combustible Solids
Hazard Classifications
Eye Irrit. 2Skin Irrit. 2STOT SE 3
Use ClassificationPharmaceuticals
Anwendungen · 2 Einträge

BeschreibungDiacerein is a disease-modifying antirheumatic drug (DMARD), reported to be useful in the treatment of various inflammatory conditions, including osteoarthritis. It forms water soluble chelates with calcium and copper, acting ultimately to reduce the activity of lysosomal enzymes and decrease the formation of rheumatoid factor.

VerwendenDiacerein is a diacetyl precursor of rhein, an anthraquinone found in plants. Rhein, at 10 μM, inhibits IL-1β signaling, suppressing signaling through NF-κB and AP-1, and reduces the expression of the matrix metalloproteases MMP-1 and MMP-13. Diacerein, presumably after conversion to rhein, down-regulates the expression of the IL-1β receptor on articular chondrocytes, enhances the expression of TGF-β, and increases collagen and aggrecan. It does not alter COX activity. It is mildly effective in ameliorating osteoarthritis.

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

9,10-Dihydro-4,5-dihydroxy-9,10-dioxoanthracen-2-carbonsure